Tilt-in space seating specialist Kirton Healthcare managed to make an operating profit of more than £100,000 in its last financial period, but this was offset by £1.4m of costs associated with its acquisition by Direct Healthcare Group (DHG).
During the period it was taken over, Kirton made a total loss of just over £1.3m. But its sales climbed by £2m to £9m during the 17 month period to 31st May 2017, according to the business’s latest financial report, published on Companies House yesterday.
The directors’ strategic report however, said sales were impacted by Kirton’s decision to curtail its sensory business and refocus on its clinical seating products, which they said performed within expectation during the period.
Kirton was DHG’s second acquisition since private equity firm NorthEdge Capital supported an MBO in April 2016. Last month DHG also took over the Transflo Cushion brand from Karomed in a deal which will see it assume the production and sales of the product from today.
Kirton, based in Haverhill, has more than 30 years’ experience in the design and manufacture of specialist seating solutions for a range of healthcare sectors.
Its specialist chairs are configured to suit a range of patient requirements and provide postural support and increased patient independence.
Based in Caerphilly, DHG specialises in the development of clinically effective solutions for harm-free patient care. It has around 190 employees and a turnover of £21m.